CKAP4 — Cytoskeleton-Associated Protein 4

CKAP4 — Cytoskeleton-Associated Protein 4

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CKAP4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CKAP4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cytoskeleton-Associated Protein 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10527</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000129195</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>616404</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q07011</td>
</tr>
<tr>
<td class="label">Protein Aliases</td>
<td>CLIMP-63, ERGIC-53, LBP</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>ALS, Alzheimer's Disease, Cancer</td>
</tr>
</table>

CKAP4 — Cytoskeleton-Associated Protein 4

Overview

CKAP4 — Cytoskeleton-Associated Protein 4

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CKAP4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CKAP4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cytoskeleton-Associated Protein 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>12p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10527</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000129195</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>616404</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q07011</td>
</tr>
<tr>
<td class="label">Protein Aliases</td>
<td>CLIMP-63, ERGIC-53, LBP</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>ALS, Alzheimer's Disease, Cancer</td>
</tr>
</table>

CKAP4 — Cytoskeleton-Associated Protein 4

Overview

CKAP4 (Cytoskeleton-Associated Protein 4), also known as CLIMP-63 (Cytoskeleton Linker Membrane Protein of 63 kDa) or ERGIC-53 (ER-Golgi Intermediate Compartment protein of 53 kDa), is a type II transmembrane protein localized to the endoplasmic reticulum (ER), ER-Golgi intermediate compartment (ERGIC), and nuclear envelope. The protein plays critical roles in maintaining ER morphology, organizing microtubules, and facilitating protein trafficking between cellular compartments["@shimura2005"].

Located on chromosome 12p13.1, CKAP4 is highly expressed in the brain, particularly in motor neurons of the spinal cord and motor cortex. The protein has been implicated in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease, and several cancers. CKAP4 functions as a receptor for DICKKOPF1 (DKK1), linking Wnt signaling to cytoskeletal dynamics and cellular stress responses["@yuan2019"].

Function

Protein Structure and Topology

CKAP4 is a type II transmembrane protein with the following structural features[@shimura2005]:

• N-terminal cytosolic domain (1-400 aa): Contains binding sites for microtubules and chromatin-associated proteins
• Transmembrane domain (401-423 aa): Single pass membrane spanning region
• C-terminal lumenal domain (424-586 aa): ER lumen-facing domain that interacts with cargo proteins

Microtubule Organization

CKAP4 is a microtubule-binding protein critical for cytoskeletal organization[@tanaka2018]:

• Microtubule Binding: The cytosolic domain binds directly to microtubules, stabilizing the network
• ER-Microtubule Interaction: CKAP4 tethers ER membranes to microtubules, maintaining ER morphology
• Centrosome Association: Localizes to centrosomes in some cell types, influencing spindle orientation
• Axonal Transport Support: Facilitates proper organization of microtubules in axons

ER Morphology and Function

CKAP4 plays a central role in ER organization[@nagai2007][@sato2016]:

• ER Sheet Formation: CKAP4 oligomers create flat ER sheets with ribosome-studded cytoplasmic surfaces
• ER Positioning: Tethers ER membranes to microtubules, positioning organelles within the cell
• Protein Trafficking: Facilitates trafficking between ER and Golgi compartments
• Nuclear Envelope: Contributes to nuclear envelope structure and function

CKAP4 as DKK1 Receptor

CKAP4 functions as a cell surface receptor for the Wnt antagonist DKK1[@yuan2019]:

• DKK1 Binding: CKAP4 binds DKK1 with high affinity, mediating its effects on cell signaling
• Wnt Pathway Modulation: DKK1-CKAP4 signaling antagonizes canonical Wnt/β-catenin signaling
• Cellular Effects: DKK1-CKAP4 axis affects cell proliferation, migration, and survival
• Pathological Relevance: Elevated DKK1 in Alzheimer's disease may signal through CKAP4 to promote neurodegeneration

Protein Quality Control

CKAP4 participates in cellular protein quality control mechanisms[@konishi2014]:

• Aggresome Formation: CKAP4 localizes to aggresomes, perinuclear inclusions containing misfolded proteins
• Autophagy Regulation: Involved in targeting proteins for autophagic degradation
• ERAD Components: Associates with ER-associated degradation machinery
• Stress Response: Upregulated during cellular stress conditions

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

CKAP4 is strongly implicated in ALS pathogenesis through multiple mechanisms[@saitoh2020][@kido2018][@fuchigami2020]:

Motor Neuron Vulnerability:

• CKAP4 is highly expressed in spinal cord motor neurons
• Motor neurons show particular susceptibility to CKAP4 dysfunction
• The protein is abundant in large, metabolically active neurons

• CKAP4 aggregates have been observed in motor neurons of ALS patients
• Co-localization with TDP-43 inclusions in some cases
• CKAP4 aggregation may represent a cellular response to proteostatic stress

• CKAP4 dysfunction contributes to ER stress, a key feature of ALS
• Impaired ER morphology observed in ALS models with CKAP4 knockdown
• ER stress triggers apoptotic pathways in motor neurons

• CKAP4 organizes axonal microtubules essential for transport
• Dysfunction may contribute to defects in vesicle trafficking
• Impaired axonal transport is an early event in ALS pathogenesis

• Some CKAP4 variants have been associated with ALS risk
• Further studies needed to confirm genetic associations

Alzheimer's Disease

CKAP4 contributes to AD pathogenesis through DKK1 signaling[@chen2018][@yuan2019]:

DKK1 Overexpression:

• DKK1 is elevated in AD brain tissue
• CKAP4 mediates DKK1's effects on neurons
• DKK1-CKAP4 signaling promotes synaptic dysfunction

• Canonical Wnt signaling is impaired in AD
• DKK1-CKAP4 axis further inhibits Wnt signaling
• Wnt pathway dysfunction affects synaptic plasticity and memory

• CKAP4 organizes ER crucial for calcium homeostasis
• ER stress is a feature of AD neurons
• CKAP4 may contribute to calcium dysregulation

Cancer

CKAP4 is overexpressed in several malignancies and functions as[@nogawa2012]:

Oncogenic Functions:

• Marker for poor prognosis in pancreatic cancer
• Promotes cell proliferation and survival
• Associated with aggressive tumor phenotypes

• Serum CKAP4 as a biomarker for pancreatic cancer
• Potential for early detection in high-risk populations

Molecular Mechanisms

ER-Microtubule Dysfunction in ALS

The primary disease mechanism involves ER-microtubule network disruption[@tanaka2018][@ishihara2022]:

DKK1-CKAP4 Signaling in Neurodegeneration

The DKK1-CKAP4 axis promotes neurodegeneration through[@yuan2019]:

Aggregation and Proteostasis

CKAP4 participates in protein aggregation pathways[@konishi2014]:

• Aggresome Targeting: CKAP4 helps target misfolded proteins to aggresomes
• Autophagy Engagement: Links aggregation to autophagic degradation
• Stress Granule Association: May interact with stress granule components
• Clearance Failure: In ALS, this system becomes overwhelmed

Therapeutic Approaches

ALS Therapeutic Strategies

| Approach | Target | Status | Rationale |
|----------|--------|--------|-----------|
| CKAP4 modulators | Protein expression | Preclinical | Reduce aggregation |
| ER stress inhibitors | UPR pathways | Research | Protect motor neurons |
| Microtubule stabilizers | Cytoskeleton | Experimental | Restore axonal transport |
| Autophagy enhancers | Clearance pathways | Research | Boost protein clearance |
| DKK1 blockade | CKAP4 signaling | Preclinical | Protect synapses |

Alzheimer's Disease

| Approach | Target | Status |
|----------|--------|--------|
| DKK1 inhibitors | Antibody/small molecule | Preclinical |
| Wnt pathway activators | β-catenin stabilization | Research |
| CKAP4 modulators | Expression/function | Early research |

Challenges

• Blood-brain barrier limits delivery of biologics
• CKAP4 has essential functions, making complete inhibition problematic
• Timing of intervention critical - late-stage disease may not benefit
• Motor neuron-specific delivery remains challenging

See Also

• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [ER Stress](/mechanisms/er-stress-unfolded-protein-response)
• [Axonal Transport](/mechanisms/axonal-transport)
• [Microtubules](/mechanisms/cytoskeleton-microtubules)
• [Protein Aggregation](/mechanisms/protein-aggregation-misfolding-neurodegeneration)
• [Wnt Signaling](/mechanisms/wnt-signaling-pathway)

External Links

• [NCBI Gene: CKAP4](https://www.ncbi.nlm.nih.gov/gene/10527)
• [UniProt: Q07011](https://www.uniprot.org/uniprot/Q07011)
• [OMIM: 616404](https://omim.org/entry/616404)
• [GeneCards: CKAP4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CKAP4)
• [Allen Brain Atlas: CKAP4](https://human.brain-map.org/microarray/search/show?search_term=CKAP4)

Pathway Diagram

The following diagram shows the key molecular relationships involving CKAP4 — Cytoskeleton-Associated Protein 4 discovered through SciDEX knowledge graph analysis: